mci 225 has been researched along with scopolamine hydrobromide in 1 studies
| Studies (mci 225) | Trials (mci 225) | Recent Studies (post-2010) (mci 225) | Studies (scopolamine hydrobromide) | Trials (scopolamine hydrobromide) | Recent Studies (post-2010) (scopolamine hydrobromide) |
|---|---|---|---|---|---|
| 8 | 0 | 0 | 7,548 | 563 | 1,401 |
| Protein | Taxonomy | mci 225 (IC50) | scopolamine hydrobromide (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.003 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 0.006 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.0006 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0026 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egawa, M; Eguchi, J; Tobe, A; Yuasa, T | 1 |
1 other study(ies) available for mci 225 and scopolamine hydrobromide
| Article | Year |
|---|---|
Effects of a novel compound MCI-225 on impaired learning and memory in rats.
Topics: Animals; Avoidance Learning; Behavior, Animal; Carbon Dioxide; Cholinesterase Inhibitors; Learning Disabilities; Male; Memory Disorders; Motor Activity; Orientation; Piperazines; Psychotropic Drugs; Pyrimidines; Rats; Rats, Wistar; Scopolamine; Tacrine | 1994 |